In the past decade, while a number of case–control studies have been carried out to investigate the relationships between LIPC or CETP polymorphisms and risk of atherosclerosis diseases[43,51,52,101,115], little is known about their effect on neurodegenerative disease. The gene discussed is LIPC; the disease is neurodegenerative disease.